Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407888
Status:
COMPLETED
Last Update Posted:
2017-08-31
First Post:
2006-12-04
Brief Title:
Doxorubicin Hydrochloride Cyclophosphamide and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Breast Cancer |
| Estrogen Receptor-positive Breast Cancer |
| HER2-positive Breast Cancer |
| Stage IA Breast Cancer |
| Stage IB Breast Cancer |
| Stage II Breast Cancer |
| Stage IIIA Breast Cancer |
| Stage IIIB Breast Cancer |
| Stage IIIC Breast Cancer |
Keywords: